Cargando…
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone
BACKGROUND: Pancreatic ductal adenocarcinomas (PDA) activate a glutamine-dependent pathway of cytosolic nicotinamide adenine dinucleotide phosphate (NADPH) production to maintain redox homeostasis and support proliferation. Enzymes involved in this pathway (GLS1 (mitochondrial glutaminase 1), GOT1 (...
Autores principales: | Chakrabarti, Gaurab, Moore, Zachary R., Luo, Xiuquan, Ilcheva, Mariya, Ali, Aktar, Padanad, Mahesh, Zhou, Yunyun, Xie, Yang, Burma, Sandeep, Scaglioni, Pier P., Cantley, Lewis C., DeBerardinis, Ralph J., Kimmelman, Alec C., Lyssiotis, Costas A., Boothman, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601138/ https://www.ncbi.nlm.nih.gov/pubmed/26462257 http://dx.doi.org/10.1186/s40170-015-0137-1 |
Ejemplares similares
-
Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone
por: Chakrabarti, Gaurab, et al.
Publicado: (2015) -
NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone
por: Moore, Z, et al.
Publicado: (2015) -
Pancreatic cancers depend on a non-canonical glutamine metabolism pathway
por: Lyssiotis, Costas, et al.
Publicado: (2014) -
Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance
por: Lyssiotis, Costas A., et al.
Publicado: (2013) -
Synergistic Effect of β-Lapachone and Aminooxyacetic Acid on Central Metabolism in Breast Cancer
por: Chang, Mario C., et al.
Publicado: (2022)